Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c27f4a786895417d03d0b1045587100 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 |
filingDate |
2021-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23af9e4949c66b7b788c08fe053900c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d700cf84eeef24701aae2aae4404db3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb52f79a4322446eb012da4b67834cf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf719accd8ff5d570a6defec1c742277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_248822d75b2043e28aeffff37beafde2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_233b5cc032c05fa3471a667216b68776 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6171f2f73c38aa3e0923a52e14990aab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e7d574d11670611324b845e16b21593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5e1ce26104a122c7ed277bf8380ec33 |
publicationDate |
2021-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-112500464-A |
titleOfInvention |
A kind of anti-Giardia target zinc lipoprotein and medical use |
abstract |
The invention provides a zinc lipoprotein that is an anti-Giardia target and its medical application, and discovers a protein ZFD that can significantly inhibit the reproduction of the parasite. Granzyme activity and influence on telomere length; the invention provides a new target ZFD for the treatment of giardia, and lays a foundation for future drug intervention in giardia. A new telomerase-related protein, and finding out the target of telomerase is a new way for the development of anti-Giardia drugs. |
priorityDate |
2021-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |